Name | Number of supported studies | Average coverage | |
---|---|---|---|
adipocyte | 10 studies | 61% ± 19% | |
oligodendrocyte | 6 studies | 25% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 98% | 3012.82 | 254 / 258 | 97% | 21.84 | 222 / 230 |
breast | 98% | 33269.88 | 450 / 459 | 85% | 12.91 | 946 / 1118 |
brain | 70% | 1551.48 | 1859 / 2642 | 98% | 13.39 | 694 / 705 |
bladder | 43% | 671.52 | 9 / 21 | 87% | 7.54 | 437 / 504 |
thymus | 33% | 511.04 | 214 / 653 | 97% | 5.39 | 585 / 605 |
intestine | 26% | 554.57 | 247 / 966 | 92% | 6.02 | 484 / 527 |
uterus | 27% | 306.06 | 46 / 170 | 88% | 7.01 | 404 / 459 |
skin | 28% | 776.27 | 515 / 1809 | 85% | 5.67 | 400 / 472 |
esophagus | 13% | 230.84 | 186 / 1445 | 89% | 5.12 | 163 / 183 |
adipose | 100% | 42082.08 | 1204 / 1204 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 6.52 | 1 / 1 |
lymph node | 0% | 0 | 0 / 0 | 97% | 7.92 | 28 / 29 |
eye | 0% | 0 | 0 / 0 | 96% | 4.54 | 77 / 80 |
stomach | 6% | 207.97 | 20 / 359 | 84% | 6.08 | 241 / 286 |
pancreas | 3% | 43.12 | 9 / 328 | 85% | 5.77 | 151 / 178 |
tonsil | 0% | 0 | 0 / 0 | 84% | 9.24 | 38 / 45 |
spleen | 84% | 1013.63 | 202 / 241 | 0% | 0 | 0 / 0 |
ovary | 3% | 23.98 | 5 / 180 | 77% | 4.46 | 330 / 430 |
kidney | 9% | 206.02 | 8 / 89 | 62% | 2.62 | 563 / 901 |
lung | 2% | 22.00 | 13 / 578 | 65% | 3.20 | 750 / 1155 |
prostate | 17% | 194.65 | 41 / 245 | 50% | 1.57 | 250 / 502 |
heart | 52% | 915.40 | 444 / 861 | 0% | 0 | 0 / 0 |
muscle | 33% | 433.05 | 264 / 803 | 0% | 0 | 0 / 0 |
liver | 0% | 0 | 0 / 226 | 15% | 0.93 | 61 / 406 |
blood vessel | 14% | 943.53 | 189 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 8% | 83.54 | 77 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0008203 | Biological process | cholesterol metabolic process |
GO_0046340 | Biological process | diacylglycerol catabolic process |
GO_0016042 | Biological process | lipid catabolic process |
GO_0019433 | Biological process | triglyceride catabolic process |
GO_0042572 | Biological process | retinol metabolic process |
GO_0006468 | Biological process | protein phosphorylation |
GO_0046485 | Biological process | ether lipid metabolic process |
GO_0005811 | Cellular component | lipid droplet |
GO_0016020 | Cellular component | membrane |
GO_0005901 | Cellular component | caveola |
GO_0005829 | Cellular component | cytosol |
GO_0004806 | Molecular function | triglyceride lipase activity |
GO_0033878 | Molecular function | hormone-sensitive lipase activity |
GO_0047376 | Molecular function | all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity |
GO_0004771 | Molecular function | sterol esterase activity |
GO_0102259 | Molecular function | 1,2-diacylglycerol acylhydrolase activity |
GO_0050253 | Molecular function | retinyl-palmitate esterase activity |
GO_0047372 | Molecular function | acylglycerol lipase activity |
GO_0102258 | Molecular function | 1,3-diacylglycerol acylhydrolase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | LIPE |
Protein name | Lipase E, hormone sensitive type Hormone-sensitive lipase (HSL) (EC 3.1.1.79) (Monoacylglycerol lipase LIPE) (EC 3.1.1.23) (Retinyl ester hydrolase) (REH) |
Synonyms | |
Description | FUNCTION: Lipase with broad substrate specificity, catalyzing the hydrolysis of triacylglycerols (TAGs), diacylglycerols (DAGs), monoacylglycerols (MAGs), cholesteryl esters and retinyl esters . Shows a preferential hydrolysis of DAGs over TAGs and MAGs and preferentially hydrolyzes the fatty acid (FA) esters at the sn-3 position of the glycerol backbone in DAGs . Preferentially hydrolyzes FA esters at the sn-1 and sn-2 positions of the glycerol backbone in TAGs (By similarity). Catalyzes the hydrolysis of 2-arachidonoylglycerol, an endocannabinoid and of 2-acetyl monoalkylglycerol ether, the penultimate precursor of the pathway for de novo synthesis of platelet-activating factor (By similarity). In adipose tissue and heart, it primarily hydrolyzes stored triglycerides to free fatty acids, while in steroidogenic tissues, it principally converts cholesteryl esters to free cholesterol for steroid hormone production (By similarity). . |
Accessions | ENST00000244289.9 [Q05469-1] ENST00000599211.1 M0QXB1 ENST00000599783.5 ENST00000601189.1 ENST00000597620.5 M0R2G1 ENST00000599918.1 ENST00000597001.1 M0QYP8 M0QXM5 Q05469 M0R201 M0QY29 |